Framework Section D 2.0
  • Section D. Constant monitoring of the evidence (guide and report)

  • This section seeks to support the evidence surveillance and monitoring process regardless of how often it is planned to be carried out. A series of questions are presented that will guide the user in applying the appropriate criteria to determine when to incorporate the identified evidence into the existing synthesis ("baseline synthesis") and the knowledge transfer product that it supports.
    The format allows collecting the necessary information to generate a report of results each time this step is carried out for the identification of new evidence.

  • This is monitoring (Nº)     done for this question.

  •  - -
  • Step 1. Results of the follow-up and monitoring process

    This step will allow you to document the process of monitoring and evaluating the evidence each time you do it. Completing it will allow you to have the information to update the PRISMA flowchart and other aspects of your living evidence synthesis report.

  • Rows
  • Rows
  • Step 2. Is it justified to incorporate the new evidence into the existing synthesis?

    The following flowchart allows you to apply the criteria that will determine to update existing evidence synthesis when new eligible studies emerge.

  • Image field 77
  • Rows
  • Step 3. Revisit the PICO and the LE parameters.

    This step will allow you to define if the PICO question is still relevant or if it warrants any modification according to the results of the last evidence monitoring and update.

  • Note. If you have changed the PICO it is desirable that you take time to revisit the search strategy to ensure the searches will capture the relevant evidence for the new question. At this point you should update Section A of the Framework.

  • Step 4. Integration into transfer products

    This step seeks to help you determine whether the new evidence has the potential to impact the current conclusions of the product it supports (i.e., recommendation in a CPG, HTA report or Policy Brief). Consequently, it can lead to their immediate integration or an extraordinary change in the regular/planned update processes.

  • Image field 80
  • If you answered yes to any of the questions above, consider incorporating immediately the new evidence into the transfer product it supports.

     

    Note: Relevant changes in the conclusions that imply changes in current clinical practice should be promptly reported to the reader and the main stakeholders involved. Regarding the publication, it will be necessary to define the actions to achieve greater speed in the editorial process.

  • Next, press "submit". A PDF document will be generated. Keep that document among the documents that support the process of this evidence synthesis.

  • Should be Empty: